Cargando…
Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis
Resting tumor cells represent a huge challenge during anticancer therapy due to their increased treatment resistance. TNF-related apoptosis-inducing ligand (TRAIL) is a putative future anticancer drug, currently in phases I and II clinical studies. We recently showed that TRAIL is able to target leu...
Autores principales: | Ehrhardt, H, Wachter, F, Grunert, M, Jeremias, I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698546/ https://www.ncbi.nlm.nih.gov/pubmed/23744361 http://dx.doi.org/10.1038/cddis.2013.179 |
Ejemplares similares
-
Impact of the p53 status of tumor cells on extrinsic and intrinsic apoptosis signaling
por: Wachter, Franziska, et al.
Publicado: (2013) -
Combination Therapy of TRAIL and Thymoquinone Induce Breast Cancer Cell Cytotoxicity-Mediated Apoptosis and Cell Cycle Arrest
por: Abdel Salam, Nagwa M, et al.
Publicado: (2021) -
Splicing reprogramming of TRAIL/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis
por: Voss, Oliver H., et al.
Publicado: (2021) -
HTNV Sensitizes Host Toward TRAIL-Mediated Apoptosis—A Pivotal Anti-hantaviral Role of TRAIL
por: Chen, Qing-Zhou, et al.
Publicado: (2020) -
The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL
por: Grunert, M, et al.
Publicado: (2012)